Clinical trial
PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19
NCT05075941 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19
- Lead sponsor
- Epicentre
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 15, 2021
- Completion date
- December 22, 2021
- Enrollment
- 3,811 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.